Testsealabs Tick-borne encephalitis virus TBE Rapid Test Kit

Name: Testsealabs Tick-borne encephalitis virus TBE Rapid Test Kit
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 1936977141

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.60

2,000-9,999 Pieces

US$0.50

10,000-49,999 Pieces

US$0.37

50,000+ Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

Rapid Diagnostic Test

Format

Cassette

Model NO.

10100-TBE

Specimen

Whole Blood/Serum/Plasma

Sensitity

98.5%

Specificity

99.1%

Box Specification

25/40 Tests/Box

Quantity Per Carton

1000 Tests

Certificate

ISO 13485

Weight/Carton

12.00kg

Shelf Life

24 Months

Test Time

15 Minutes

Instrument Classification

Class III

Transport Package

66*36*56.5cm

Specification

268*124*65mm

Trademark

Testsealabs

Origin

China

HS Code

3822190090

Production Capacity

3000000/Day

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤10.66h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology, based in Hangzhou, China, is a company founded in 2015 specializing in the R&D, production, and sale of in vitro diagnostic and veterinary products. The company holds ISO 9001 and GMP certifications, indicating robust quality management systems. With over 10 production lines and an annual production output between US$50 million and US$100 million, Testsea demonstrates substantial production capability. The company exports extensively, with 90% of sales derived from international markets. Testsea emphasizes innovation through its development of core technologies for diagnostic testing and offers a wide range of rapid test products.

Supplier typeTestsea Biotechnology is a trading company and manufacturer/factory based in Zhejiang, China.

CertificationsThe company holds ISO 9001 and GMP certifications, indicating adherence to quality management standards.

R&D capabilityThe company focuses on R&D and has built detection platforms, indicating strong innovation capabilities.

Production capacityWith over 10 production lines and an annual output of US$50M - US$100M, the company has substantial production capacity.

Client casesThe company's products are used globally in over 100 countries for various rapid diagnostic applications.